Long-Term Weight Loss & Maintenance with Semaglutide in Obesity (2022 Review of STEP Trials) consolidates findings across multiple STEP trials (1, 3, 4, 8), showing 14.917.4% mean weight loss over 68 weeks, improved cardiometabolic markers, and better quality-of-life outcomes
Williams-Karnesky, R
J Clin Oncol 19(3):851856 Reichert J et al (2010) Development trends for peptide therapeutics
In order to search for glutathione transferase (GST) inhibitors, a novel method was designed
In the case of peptide 20- and tirzepatide-bound GIPR complexes, the side chain of E253 ICL2 contributed one salt bridge with K34 GHN , not observed in the peptide 20-bound GLP-1R and GCGR complexes (Fig
This provides compelling evidence that GLP-1RAs could be a potential target for SA treatment